Inflammation in Macrophages Found as a Driving Force in Rare Genetic Conditions Researchers at The Hospital for Sick Children (SickKids) have uncovered that inflammation in macrophages may be responsible in part for some severe symptoms in a group of rare genetic conditions called lysosomal storage diseases (LSDs).
Genetic Engineering & Biotechnology News
Book and Periodical Publishing
New Rochelle, New York 178,188 followers
The Bedrock of Biotech
About us
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.
- Website
-
http://www.genengnews.com
External link for Genetic Engineering & Biotechnology News
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- New Rochelle, New York
- Type
- Privately Held
- Founded
- 1981
- Specialties
- Biotechnology, Drug Discovery, Bioprocessing, Translational Medicine, OMICS, and Genome Editing
Locations
-
Primary
140 Huguenot St
New Rochelle, New York 10801, US
Employees at Genetic Engineering & Biotechnology News
Updates
-
Novel Gut Therapy May Potentially Be Used to Protect against Adult-Onset Asthma Early exposure to antibiotics can trigger long-term susceptibility to asthma, according to scientists from Monash University. However, the researchers have isolated a molecule produced by gut bacteria that in the future could potentially be trialed as a dietary supplement therapy for children at risk of asthma to prevent them developing the disease.
Novel Gut Therapy May Potentially Be Used to Protect against Adult-Onset Asthma
genengnews.com
-
Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne Université and Qubit Pharmaceuticals Researchers have developed new algorithms that break down a quantum calculation into its various components.
Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne and Qubit Pharmaceuticals
genengnews.com
-
Phages Can Weaponize Selfish Genetic Elements to Outcompete Peers Among phages, a selfish genetic element has been found to encode an intron endonuclease that facilitates interference competition. One phage can deploy the intron endonuclease to cut the DNA of a competing virus, disrupting its reproduction. Understanding such mechanisms could lead to better phage therapy cocktails. The study was conducted by UC San Diego researchers.
Phages Can Weaponize Selfish Genetic Elements to Outcompete Peers
genengnews.com
-
Flagship Pioneering Raises $3.6B, Plans 25 New Startups Venture capital giant Flagship Pioneering plans to support the creation and development of about 25 new startups in life sciences or “human health,” sustainability, and artificial intelligence over the next three to five years with the combined $3.6 billion in new capital.
Flagship Pioneering Raises $3.6B, Plans 25 New Startups
genengnews.com
-
Mapping the World's Fungi from Air Samples DNA sequencing was used to identify fungi from air samples collected around the world to provide an integrated view of the spatial and seasonal dynamics of fungi. More specifically, the research from a group at the University of Jyväskylä in Finland, provides information about the climatic and evolutionary factors influencing the occurrence and seasonal variation of both previously known and unknown fungi.
Mapping the World's Fungi from Air Samples
genengnews.com
-
Don't miss Alex Philippidis' latest StockWatch! Illumina acquires Fluent BioSciences Inc., after GRAIL spinoff leads to Citi upgrade; Deutsche Bank downgrades single cell leader 10x Genomics, citing growing competition; Amylyx Pharmaceuticals shares climbed; HilleVax shares cratered; Indivior shares nosedived; Kazia Therapeutics Limited shares more than tripled, catapulting 248%; uniQure shares nearly tripled, zooming 168%.
StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x
genengnews.com
-
Brain Inflammation and Muscle Weakness Linked by Signaling Axis In fruit flies and mice, scientists at Washington University School of Medicine in St. Louis identify possible way to block muscle fatigue in inflammatory diseases, including bacterial infections, Alzheimer’s disease, and long COVID.
Brain Inflammation and Muscle Weakness Linked by Signaling Axis
genengnews.com
-
LAST CHANCE! Navigating the Organ-on-Chip Landscape: Latest Regulatory Insights and the Path to Widespread Adoption In this GEN Learning Lab TODAY, CN Bio’s CSO Tomasz Kostrzewski, PhD, and toxicology consultant Clive Roper BSc PhD CBiol CSci ERT FRSB, will discuss all things OOC, including current applications, the evolving perspective of regulators, and ongoing efforts to harness OOCs’ potential in biomedicine. Register now to join us for this free webinar sponsored by CN Bio: https://ow.ly/I1IE50StgOT #DrugDiscovery
-
-
Biosimilar Manufacturer Focuses on Process Optimization A biosimilar drug manufacturer is concentrating on process optimization to increase uptake of its products in lower-income countries. According to Jeffrey Hausfeld, M.D., M.B.A., chairman of the board of BioFactura, Inc. his company has relied on intensified profusion, CO2 stripping, and metabolomic analysis to reduce costs and increase yields.
Biosimilar Manufacturer Focuses on Process Optimization
genengnews.com